GUAIFENESIN 200MG- guaifenesin tablet 
Marlex Pharmaceuticals Inc

----------

Guaifenesin 200mg

GUAIFENESIN 200 MG TABLETS

MarlexPharmaceuticals, Inc.

----------

Drug Fact

Active ingredient (in each tablet)

Guaifenesin 200mg

Purpose

Expectorant

Guaifenesin 200 mg Tablets

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageway of bothersome mucus and make coughs more productive

Warnings

Ask a doctor before use if you have

Stop use and ask a doctor if

cough last more than 7 days, come back or is accompanied by fever, rash, or persistent headache. There could be signs of a serious illness. 

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

 

If pregnant or breast- feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions:

Other Information:

Inactive Ingredients:

Colloidal silicon dioxide, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid

Manufactured for & Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

Rev: 02/19TCL

PRINCIPAL DISPLAY PANEL

NDC 10135-0681-01
Guaifenesin
200 mg
100 TABLETS

PRINCIPAL DISPLAY PANEL
NDC 10135-0681-01
Guaifenesin
200 mg
100 TABLETS

PRINCIPAL DISPLAY PANEL
NDC 10135-0681-01
Guaifenesin
200 mg
100 TABLETS

GUAIFENESIN 200MG 
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-681
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POVIDONE (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize8mm
FlavorImprint Code G2
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10135-681-01100 in 1 BOTTLE; Type 0: Not a Combination Product03/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01203/01/2019
Labeler - Marlex Pharmaceuticals Inc (782540215)

Revised: 10/2024
Document Id: 23e49e23-6685-b26b-e063-6294a90ac9aa
Set id: 5c04a60e-8a73-48b2-88ec-3b0d4b597412
Version: 5
Effective Time: 20241007
 
Marlex Pharmaceuticals Inc